Fund profile
Tickers
IBBQ
Fund manager
Total assets
$33.20 mm
Liabilities
$7.03 mm
Net assets
$26.17 mm
Number of holdings
226.00
IBBQ stock data
Top 200 of 226 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Invesco Private Prime Fund | 4.99 mm | 4.99 mm shares | 19.07 | Short-term investment vehicle | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 2.29 mm | 5.44 k shares | 8.74 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 2.27 mm | 2.35 k shares | 8.66 | Common equity | Long | USA |
Invesco Private Government Fund | 2.04 mm | 2.04 mm shares | 7.78 | Short-term investment vehicle | Long | USA |
AMGN AMGEN Inc. | 1.96 mm | 7.16 k shares | 7.49 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 1.82 mm | 25.20 k shares | 6.94 | Common equity | Long | USA |
AstraZeneca PLC, ADR
|
958.68 k | 14.94 k shares | 3.66 | Common equity | Long | UK |
MRNA Moderna Inc | 945.09 k | 10.25 k shares | 3.61 | Common equity | Long | USA |
BIIB Biogen Inc | 845.18 k | 3.90 k shares | 3.23 | Common equity | Long | USA |
ILMN Illumina Inc | 596.37 k | 4.27 k shares | 2.28 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 510.08 k | 3.38 k shares | 1.95 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 436.84 k | 5.06 k shares | 1.67 | Common equity | Long | USA |
VTRS Viatris Inc | 398.85 k | 32.24 k shares | 1.52 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 364.38 k | 12.01 k shares | 1.39 | Common equity | Long | UK |
SNY Sanofi | 360.98 k | 7.54 k shares | 1.38 | Common equity | Long | France |
INCY Incyte Corp. | 351.39 k | 6.02 k shares | 1.34 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 343.73 k | 2.64 k shares | 1.31 | Common equity | Long | USA |
MEDP Medpace Holdings Inc | 328.35 k | 826.00 shares | 1.25 | Common equity | Long | USA |
ARGX Argen X SE | 326.81 k | 860.00 shares | 1.25 | Common equity | Long | Netherlands |
SRPT Sarepta Therapeutics Inc | 321.16 k | 2.51 k shares | 1.23 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 319.94 k | 1.02 k shares | 1.22 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 286.11 k | 1.27 k shares | 1.09 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 247.84 k | 21.66 k shares | 0.95 | Common equity | Long | Bermuda |
BNTX BioNTech SE | 230.58 k | 2.59 k shares | 0.88 | Common equity | Long | Germany |
ASND Ascendis Pharma A/S | 227.55 k | 1.54 k shares | 0.87 | Common equity | Long | Denmark |
PCVX Vaxcyte Inc | 214.08 k | 2.90 k shares | 0.82 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 200.47 k | 1.69 k shares | 0.77 | Common equity | Long | Ireland |
APLS Apellis Pharmaceuticals Inc | 197.93 k | 3.19 k shares | 0.76 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 190.64 k | 2.64 k shares | 0.73 | Common equity | Long | USA |
BeiGene, Ltd., ADR
|
188.51 k | 1.14 k shares | 0.72 | Common equity | Long | Cayman Islands |
EXEL Exelixis Inc | 183.26 k | 8.37 k shares | 0.70 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 179.85 k | 2.59 k shares | 0.69 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 179.39 k | 2.13 k shares | 0.69 | Common equity | Long | Switzerland |
IONS Ionis Pharmaceuticals Inc | 174.24 k | 3.85 k shares | 0.67 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 159.96 k | 4.68 k shares | 0.61 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 152.62 k | 1.63 k shares | 0.58 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 141.05 k | 3.54 k shares | 0.54 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 140.16 k | 2.15 k shares | 0.54 | Common equity | Long | Cayman Islands |
IMVT Immunovant Inc | 138.01 k | 3.90 k shares | 0.53 | Common equity | Long | USA |
ALKS Alkermes plc | 132.98 k | 4.48 k shares | 0.51 | Common equity | Long | Ireland |
RVMD Revolution Medicines Inc | 130.21 k | 4.42 k shares | 0.50 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 129.04 k | 1.53 k shares | 0.49 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 123.53 k | 523.00 shares | 0.47 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 119.76 k | 751.00 shares | 0.46 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 114.09 k | 2.21 k shares | 0.44 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 109.97 k | 6.91 k shares | 0.42 | Common equity | Long | USA |
INSM Insmed Inc | 107.33 k | 3.87 k shares | 0.41 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 105.93 k | 3.30 k shares | 0.40 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 104.25 k | 1.28 k shares | 0.40 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 102.23 k | 4.40 k shares | 0.39 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 100.85 k | 7.87 k shares | 0.39 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 98.79 k | 3.07 k shares | 0.38 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 95.12 k | 1.93 k shares | 0.36 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 94.21 k | 2.00 k shares | 0.36 | Common equity | Long | Canada |
FTRE Fortrea Holdings Inc | 90.28 k | 2.41 k shares | 0.34 | Common equity | Long | USA |
ACLX Arcellx Inc | 86.68 k | 1.32 k shares | 0.33 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 86.60 k | 2.19 k shares | 0.33 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc | 86.21 k | 18.99 k shares | 0.33 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 85.63 k | 18.10 k shares | 0.33 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 78.24 k | 2.44 k shares | 0.30 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 78.09 k | 1.75 k shares | 0.30 | Common equity | Long | USA |
MRUS Merus N.V | 75.77 k | 1.56 k shares | 0.29 | Common equity | Long | Netherlands |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 74.62 k | 5.54 k shares | 0.29 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 74.37 k | 3.76 k shares | 0.28 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 74.10 k | 1.81 k shares | 0.28 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 70.61 k | 2.41 k shares | 0.27 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 69.82 k | 1.61 k shares | 0.27 | Common equity | Long | USA |
ARVN Arvinas Inc | 68.83 k | 1.50 k shares | 0.26 | Common equity | Long | USA |
VERA Vera Therapeutics Inc - Ordinary Shares | 66.01 k | 1.40 k shares | 0.25 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 63.67 k | 1.49 k shares | 0.24 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 61.99 k | 1.76 k shares | 0.24 | Common equity | Long | USA |
Immunocore Holdings PLC, ADR
|
61.37 k | 913.00 shares | 0.23 | Common equity | Long | UK |
KROS Keros Therapeutics Inc | 61.22 k | 907.00 shares | 0.23 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 60.31 k | 1.54 k shares | 0.23 | Common equity | Long | USA |
GH Guardant Health Inc | 59.89 k | 3.15 k shares | 0.23 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals Inc | 59.66 k | 1.28 k shares | 0.23 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 59.19 k | 5.90 k shares | 0.23 | Common equity | Long | USA |
ARDX Ardelyx Inc | 58.99 k | 6.33 k shares | 0.23 | Common equity | Long | USA |
JANX Janux Therapeutics Inc | 58.83 k | 1.22 k shares | 0.22 | Common equity | Long | USA |
VCEL Vericel Corp | 58.33 k | 1.28 k shares | 0.22 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 57.57 k | 2.14 k shares | 0.22 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 56.61 k | 2.01 k shares | 0.22 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 52.41 k | 2.24 k shares | 0.20 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 50.24 k | 1.57 k shares | 0.19 | Common equity | Long | USA |
MORF Morphic Holding Inc | 49.92 k | 1.35 k shares | 0.19 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 49.39 k | 2.36 k shares | 0.19 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 48.45 k | 1.50 k shares | 0.19 | Common equity | Long | USA |
VCYT Veracyte Inc | 46.96 k | 1.99 k shares | 0.18 | Common equity | Long | USA |
AMAM Ambrx Biopharma Inc. | 46.74 k | 1.67 k shares | 0.18 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 46.63 k | 1.54 k shares | 0.18 | Common equity | Long | USA |
INBX Inhibrx Inc | 46.48 k | 1.27 k shares | 0.18 | Common equity | Long | USA |
APGE Apogee Therapeutics Inc. | 44.67 k | 1.28 k shares | 0.17 | Common equity | Long | USA |
IRON Disc Medicine Inc | 43.95 k | 640.00 shares | 0.17 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 43.53 k | 3.44 k shares | 0.17 | Common equity | Long | USA |
NVCR NovoCure Ltd | 43.50 k | 2.84 k shares | 0.17 | Common equity | Long | Jersey |
SUPN Supernus Pharmaceuticals Inc | 42.89 k | 1.44 k shares | 0.16 | Common equity | Long | USA |
KURA Kura Oncology Inc | 41.82 k | 1.98 k shares | 0.16 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 41.71 k | 1.03 k shares | 0.16 | Common equity | Long | Cayman Islands |
EWTX Edgewise Therapeutics Inc | 40.53 k | 2.48 k shares | 0.15 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 40.38 k | 1.50 k shares | 0.15 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 40.13 k | 3.57 k shares | 0.15 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 40.06 k | 4.25 k shares | 0.15 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 39.32 k | 1.43 k shares | 0.15 | Common equity | Long | Ireland |
CFRXQ CONTRAFECT Corp | 39.31 k | 7.11 k shares | 0.15 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 38.95 k | 2.33 k shares | 0.15 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc | 38.93 k | 7.71 k shares | 0.15 | Common equity | Long | Canada |
PCRX Pacira BioSciences Inc | 37.68 k | 1.27 k shares | 0.14 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals Inc | 37.56 k | 555.00 shares | 0.14 | Common equity | Long | USA |
XNCR Xencor Inc | 37.36 k | 1.63 k shares | 0.14 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 36.98 k | 466.00 shares | 0.14 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals Inc | 36.33 k | 1.34 k shares | 0.14 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 36.25 k | 1.98 k shares | 0.14 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 36.03 k | 1.26 k shares | 0.14 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 35.55 k | 2.13 k shares | 0.14 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 34.58 k | 1.61 k shares | 0.13 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 34.49 k | 2.02 k shares | 0.13 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 33.74 k | 1.79 k shares | 0.13 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 33.14 k | 867.00 shares | 0.13 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 32.94 k | 3.29 k shares | 0.13 | Common equity | Long | USA |
ADMA Adma Biologics Inc | 32.24 k | 6.02 k shares | 0.12 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 32.19 k | 1.15 k shares | 0.12 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 31.46 k | 857.00 shares | 0.12 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 30.66 k | 5.45 k shares | 0.12 | Common equity | Long | USA |
Genmab A/S, ADR
|
30.60 k | 1.10 k shares | 0.12 | Common equity | Long | Denmark |
VRNA Verona Pharma Plc | 30.57 k | 1.78 k shares | 0.12 | Common equity | Long | UK |
AVDL Avadel Pharmaceuticals plc | 30.33 k | 2.37 k shares | 0.12 | Common equity | Long | Ireland |
TNGX Tango Therapeutics Inc | 30.21 k | 2.71 k shares | 0.12 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 29.64 k | 1.91 k shares | 0.11 | Common equity | Long | USA |
MGNX Macrogenics Inc | 29.62 k | 1.65 k shares | 0.11 | Common equity | Long | USA |
MNKD Mannkind Corp | 29.51 k | 7.18 k shares | 0.11 | Common equity | Long | USA |
OCUL Ocular Therapeutix Inc | 29.27 k | 2.91 k shares | 0.11 | Common equity | Long | USA |
GERN Geron Corp. | 28.88 k | 14.44 k shares | 0.11 | Common equity | Long | USA |
ETNB 89bio Inc | 28.23 k | 2.46 k shares | 0.11 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 28.11 k | 1.89 k shares | 0.11 | Common equity | Long | USA |
Zai Lab Ltd., ADR
|
27.82 k | 1.33 k shares | 0.11 | Common equity | Long | Cayman Islands |
Arcturus Therapeutics Holdings, Inc. | 27.52 k | 710.00 shares | 0.11 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings Inc - Ordinary Shares | 27.24 k | 3.52 k shares | 0.10 | Common equity | Long | USA |
TRML Tourmaline Bio Inc | 26.48 k | 682.00 shares | 0.10 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 26.31 k | 1.15 k shares | 0.10 | Common equity | Long | USA |
INVA Innoviva Inc | 25.85 k | 1.69 k shares | 0.10 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics Inc | 25.73 k | 2.50 k shares | 0.10 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 25.53 k | 1.61 k shares | 0.10 | Common equity | Long | USA |
Grifols, S.A., ADR
|
24.49 k | 3.26 k shares | 0.09 | Common equity | Long | Spain |
BCYC Bicycle Therapeutics Plc | 23.23 k | 926.00 shares | 0.09 | Common equity | Long | UK |
FUSN Fusion Pharmaceuticals Inc | 22.93 k | 1.92 k shares | 0.09 | Common equity | Long | Canada |
ORIC ORIC Pharmaceuticals Inc | 22.78 k | 1.79 k shares | 0.09 | Common equity | Long | USA |
EOLS Evolus Inc | 22.60 k | 1.52 k shares | 0.09 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 22.50 k | 3.75 k shares | 0.09 | Common equity | Long | UK |
ZYME Zymeworks Inc. | 22.45 k | 1.87 k shares | 0.09 | Common equity | Long | USA |
PRME Prime Medicine Inc | 22.37 k | 2.59 k shares | 0.09 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 22.00 k | 4.48 k shares | 0.08 | Common equity | Long | USA |
SLRN Acelyrin Inc | 21.90 k | 2.59 k shares | 0.08 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc | 21.79 k | 3.81 k shares | 0.08 | Common equity | Long | Canada |
EDIT Editas Medicine Inc | 21.74 k | 2.16 k shares | 0.08 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals Inc | 21.47 k | 2.57 k shares | 0.08 | Common equity | Long | USA |
CGEM Cullinan Therapeutics Inc | 21.22 k | 1.15 k shares | 0.08 | Common equity | Long | USA |
RGNX Regenxbio Inc | 20.46 k | 1.17 k shares | 0.08 | Common equity | Long | USA |
CVAC CureVac N.V. | 20.33 k | 5.94 k shares | 0.08 | Common equity | Long | Netherlands |
KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares | 19.94 k | 943.00 shares | 0.08 | Common equity | Long | Bermuda |
LYEL Lyell Immunopharma Inc | 19.59 k | 6.71 k shares | 0.07 | Common equity | Long | USA |
YMAB Y-Mabs Therapeutics Inc | 19.47 k | 1.17 k shares | 0.07 | Common equity | Long | USA |
ALXO Alx Oncology Holdings Inc | 19.35 k | 1.32 k shares | 0.07 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 18.63 k | 2.36 k shares | 0.07 | Common equity | Long | USA |
SVRA Savara Inc | 18.26 k | 3.62 k shares | 0.07 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 18.05 k | 707.00 shares | 0.07 | Common equity | Long | USA |
OABI OmniAb Inc | 18.03 k | 3.09 k shares | 0.07 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals Inc | 17.94 k | 1.45 k shares | 0.07 | Common equity | Long | USA |
GLPG Galapagos NV | 17.80 k | 507.00 shares | 0.07 | Common equity | Long | Belgium |
ALEC Alector Inc | 17.72 k | 2.54 k shares | 0.07 | Common equity | Long | USA |
ELVN Enliven Therapeutics Inc | 17.38 k | 1.09 k shares | 0.07 | Common equity | Long | USA |
FULC Fulcrum Therapeutics Inc | 16.82 k | 1.65 k shares | 0.06 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 16.73 k | 2.34 k shares | 0.06 | Common equity | Long | USA |
MLYS Mineralys Therapeutics Inc | 16.70 k | 1.09 k shares | 0.06 | Common equity | Long | USA |
BMEA Biomea Fusion Inc | 16.61 k | 949.00 shares | 0.06 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals Inc | 16.33 k | 1.53 k shares | 0.06 | Common equity | Long | USA |
LXRX Lexicon Pharmaceuticals Inc | 16.21 k | 6.51 k shares | 0.06 | Common equity | Long | USA |
NRIX Nurix Therapeutics Inc | 15.97 k | 1.29 k shares | 0.06 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 15.95 k | 2.28 k shares | 0.06 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corp | 15.88 k | 3.86 k shares | 0.06 | Common equity | Long | USA |
TSHA Taysha Gene Therapies Inc | 15.71 k | 4.97 k shares | 0.06 | Common equity | Long | USA |
NVAX Novavax, Inc. | 15.65 k | 3.17 k shares | 0.06 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 15.30 k | 1.46 k shares | 0.06 | Common equity | Long | UK |
TVTX Travere Therapeutics Inc | 15.14 k | 2.00 k shares | 0.06 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals Inc | 15.12 k | 1.11 k shares | 0.06 | Common equity | Long | USA |
URGN UroGen Pharma Ltd | 15.09 k | 823.00 shares | 0.06 | Common equity | Long | Israel |
WVE Wave Life Sciences Ltd. | 14.98 k | 3.11 k shares | 0.06 | Common equity | Long | Singapore |
PETQ PetIQ Inc - Ordinary Shares | 14.37 k | 789.00 shares | 0.05 | Common equity | Long | USA |
MRNS Marinus Pharmaceuticals Inc | 13.71 k | 1.44 k shares | 0.05 | Common equity | Long | USA |
REPL Replimune Group Inc | 13.40 k | 1.56 k shares | 0.05 | Common equity | Long | USA |
CSTL Castle Biosciences Inc | 12.89 k | 714.00 shares | 0.05 | Common equity | Long | USA |
MXCT MaxCyte Inc | 12.63 k | 2.75 k shares | 0.05 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corp | 12.51 k | 4.47 k shares | 0.05 | Common equity | Long | Canada |
TBPH Theravance Biopharma Inc | 12.48 k | 1.32 k shares | 0.05 | Common equity | Long | Cayman Islands |
HCM HUTCHMED (China) Limited | 12.48 k | 826.00 shares | 0.05 | Common equity | Long | Cayman Islands |
TERN Terns Pharmaceuticals Inc | 12.06 k | 1.65 k shares | 0.05 | Common equity | Long | USA |
VYGR Voyager Therapeutics Inc | 11.95 k | 1.44 k shares | 0.05 | Common equity | Long | USA |
HUMA Humacyte Inc | 11.95 k | 2.75 k shares | 0.05 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 11.30 k | 2.20 k shares | 0.04 | Common equity | Long | USA |
XERS Xeris Pharmaceuticals Inc | 11.29 k | 3.67 k shares | 0.04 | Common equity | Long | USA |
VTYX Ventyx Biosciences Inc | 11.06 k | 1.56 k shares | 0.04 | Common equity | Long | USA |